125 related articles for article (PubMed ID: 291471)
1. Loss of terminal deoxynucleotidyl transferase (TdT) activity as a predictor of emergence of resistance to chemotherapy in a case of chronic myelogenous leukemia in blast crisis.
Ross DD; Wiernik PH; Sarin PS; Whang-Peng J
Cancer; 1979 Nov; 44(5):1566-70. PubMed ID: 291471
[TBL] [Abstract][Full Text] [Related]
2. Terminal deoxynucleotidyl transferase in the blastic phase of chronic myelogenous leukemia: an indicator of response to vincristine and prednisone therapy.
Tanaka M; Kaneda T; Hirota Y; Yoshida S; Kitajima K
Am J Hematol; 1980; 9(3):287-93. PubMed ID: 6940442
[TBL] [Abstract][Full Text] [Related]
3. Two cases of acute myelogenous leukemia with high terminal deoxynucleotidyl transferase activity responding to vincristine-prednisolone treatment with complete remission.
Takaku F; Hida K; Sakamoto S; Kano Y; Maezawa M; Miura Y; Oshimura M
Jpn J Med; 1981 Jul; 20(3):227-31. PubMed ID: 6951069
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic changes in a case of blast crisis of CML: characterization by TdT, cytochemistry, and cytogenetics.
Paietta E; Schwarzmeier JD
Scand J Haematol; 1981 Oct; 27(4):241-6. PubMed ID: 6955937
[TBL] [Abstract][Full Text] [Related]
5. Terminal-deoxynucleotidyl-transferase immunofluorescence on bone marrow smears: serial studies on 28 patients.
Miller WM; Stass SA; Schumacher HR; Bollum FJ
Am J Hematol; 1981; 10(1):1-7. PubMed ID: 7020412
[TBL] [Abstract][Full Text] [Related]
6. Use of terminal deoxynucleotidyl transferase in the diagnosis of leukemia.
Morse EE; Gaffney J; Donskoy E; Pisciotto P; Altman A; Quinn J; Goldschneider I
Ann Clin Lab Sci; 1983; 13(2):128-32. PubMed ID: 6344744
[TBL] [Abstract][Full Text] [Related]
7. Ph1-positive acute myelocytic leukemia with high TdT levels.
Casoli C; Bonati A; Starcich BR
Cancer; 1983 Oct; 52(7):1210-4. PubMed ID: 6576848
[TBL] [Abstract][Full Text] [Related]
8. Terminal deoxynucleotidyl transferase in acute leukemias by direct immunofluorescence.
Nair CN; Gothoskar BP; Gladstone B; Badrinath Y; Chhajlani V; Karnik M; Nerurkar A; Damle SR; Redkar SL; Gopal R
Neoplasma; 1987; 34(3):305-11. PubMed ID: 3302737
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of leukemia cell terminal transferase measurements.
McCaffrey R; Lillquist A; Sallan S; Cohen E; Osband M
Cancer Res; 1981 Nov; 41(11 Pt 2):4814-20. PubMed ID: 7028251
[TBL] [Abstract][Full Text] [Related]
10. Single-cell immunofluorescence assay for terminal transferase: human leukaemic and non-leukaemic cells.
Okamura S; Crane F; Jamal N; Messner HA; Mak TW
Br J Cancer; 1980 Feb; 41(2):159-67. PubMed ID: 6989382
[TBL] [Abstract][Full Text] [Related]
11. Terminal-deoxynucleotidyl transferase (TdT): serial observations on patients with leukemia.
Schumacher HR; Haider Y; Miller WM; Stass SA; Bollum FJ
Am J Med Sci; 1983; 286(3):18-24. PubMed ID: 6356915
[TBL] [Abstract][Full Text] [Related]
12. Terminal deoxynucleotidyl transferase activities and glucocorticoid receptors in leukaemia.
Sasaki R; Takaku F; Aoki T; Bollum FJ; Saito T; Dan S
Br J Cancer; 1981 Jul; 44(1):63-7. PubMed ID: 7259961
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of terminal deoxynucleotidyl transferase and adenosine deaminase determinations in adult leukemia with a lymphoid phenotype.
Brusamolino E; Isernia P; Lazzarino M; Scovassi I; Bertazzoni U; Bernasconi C
J Clin Oncol; 1984 Aug; 2(8):871-80. PubMed ID: 6589363
[TBL] [Abstract][Full Text] [Related]
14. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
Shumak KH; Baker MA; Taub RN; Coleman MS
Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
[TBL] [Abstract][Full Text] [Related]
15. Mitoxantrone, vincristine, and prednisone in adults with relapsed or primarily refractory acute lymphocytic leukemia and terminal deoxynucleotidyl transferase positive blastic phase chronic myelocytic leukemia.
Paciucci PA; Keaveney C; Cuttner J; Holland JF
Cancer Res; 1987 Oct; 47(19):5234-7. PubMed ID: 3476201
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of terminal deoxynucleotidyl transferase activity in acute nonlymphoblastic leukemia.
Benedetto P; Mertelsmann R; Szatrowski TH; Andreeff M; Gee T; Arlin Z; Kempin S; Clarkson B
J Clin Oncol; 1986 Apr; 4(4):489-95. PubMed ID: 3958762
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of terminal transferase activity in childhood acute lymphoblastic leukemia: a prospective analysis of 164 patients.
Hutton JJ; Coleman MS; Moffitt S; Greenwood MF; Holland P; Lampkin B; Kisker T; Krill C; Kastelic JE; Valdez L; Bollum FJ
Blood; 1982 Dec; 60(6):1267-76. PubMed ID: 6958335
[TBL] [Abstract][Full Text] [Related]
18. Vincristine and prednisolone therapy in blast crisis of chronic myelogenous leukaemia in childhood.
Kano Y; Takaku F; Sakamoto S; Hida K; Kasahara T; Okamura J; Hasegawa K; Tsukada T; Sasaki H
Scand J Haematol; 1981 Nov; 27(5):323-6. PubMed ID: 6955938
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of terminal transferase and adenosine deaminase in acute and chronic myeloid leukemia.
Bertazzoni U; Brusamolino E; Isernia P; Scovassi AI; Torsello S; Lazzarino M; Bernasconi C
Blood; 1982 Sep; 60(3):685-92. PubMed ID: 7049266
[TBL] [Abstract][Full Text] [Related]
20. Terminal deoxynucleotidyl transferase activity in childhood leukemia.
Winick N; Steinherz PG; Miller DR
Cancer; 1985 May; 55(9):1943-7. PubMed ID: 3978575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]